[Form 3] Interparfums, Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Hervé Bouillonnec, Global Chief Commercial Officer and director of Interparfums, Inc. (IPAR), filed an initial Form 3 disclosing ownership of stock options. The filing lists four option grants exercisable between 12/31/2020 and 12/31/2025 that together cover 14,500 shares of common stock with exercise prices of $73.09, $97.84, $147.71, and $130.60. The Form 3 was signed by an attorney-in-fact on 09/10/2025.

Insights

Securities Analyst

TL;DR: Routine initial Section 16 filing showing executive option holdings, no unusual terms or immediate dilution.

The Form 3 documents that an executive and director holds standard employee stock options totaling 14,500 shares with staggered exercisability and expiration dates through 2030. The disclosures are typical for equity compensation and do not by themselves change capital structure or indicate material off-cycle transactions. Investors should view this as standard insider reporting.

Corporate Governance Expert

TL;DR: Governance disclosure completed; reporting person is both officer and director, filed timely initial ownership statement.

The filing identifies Hervé Bouillonnec as both a director and Global Chief Commercial Officer and provides clear option detail: grant sizes, exercise prices, and exercise/expiration windows. The Form is signed by an attorney-in-fact, which is consistent with delegated signing practices. No governance red flags or related-party arrangements are disclosed in this document.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Bouillonnec Herve

(Last) (First) (Middle)

551 5TH AVENUE

(Street)

NEW YORK NY 10176

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/10/2025

3. Issuer Name and Ticker or Trading Symbol
INTERPARFUMS INC [ IPAR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	GlobalChiefCommercialOfficer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option - Right to Buy	12/31/2020	12/30/2025	Common Stock	1,500	$73.09	D
Option - Right to Buy	12/30/2023	12/29/2028	Common Stock	5,000	$97.84	D
Option - Right to Buy	12/29/2024	12/28/2029	Common Stock	4,000	$147.71	D
Option - Right to Buy	12/31/2025	12/30/2030	Common Stock	4,000	$130.6	D

Explanation of Responses:

	/s/ Herve Bouillonnec By Joseph A. Caccamo as Attorney in Fact	09/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What securities did Hervé Bouillonnec disclose on Form 3 for IPAR?

The filing discloses four stock option grants covering 14,500 common shares in total.

What are the exercise prices and share counts of the options disclosed?

Options: 1,500 at $73.09, 5,000 at $97.84, 4,000 at $147.71, and 4,000 at $130.60.

When are the options exercisable and when do they expire?

Exercise dates range from 12/31/2020 to 12/31/2025; expiration dates range from 12/30/2025 to 12/30/2030 as listed in the filing.

What is Hervé Bouillonnec’s relationship to Interparfums (IPAR)?

The Form 3 states he is a Director and an Officer with the title Global Chief Commercial Officer.

When was the Form 3 filed and who signed it?

The Form 3 is dated and signed on 09/10/2025 by an attorney-in-fact, Joseph A. Caccamo, on behalf of Hervé Bouillonnec.